Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Learn which blue chip coins to buy in 2026 and why they stand out in terms of reliability, liquidity, and long-term potential.
25,977 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
The February 2026 jobs report shows a surprising payroll pullback, with 92,000 fewer positions. Unemployment rose to ...
A Senate staff brief on the ROAD to Housing Act flags design flaws and local zoning reliance, signaling lenders and b...
A new analysis puts the value of unpaid caregiving at $683 billion, highlighting the economic weight carried by women...
DC Blockchain Summit presses ahead in Washington as Dubai's Token2049 is delayed amid geopolitical risk, highlighting...
One year into Lip-Bu Tan’s tenure, Intel trimmed costs, pushed 18A production forward, and rebuilt the balance sheet—...
A massive ground-level image map built by pokémon players is now training robots that deliver meals and packages acro...
Super Micro Computer faces a looming risk of removal from the S&P 500 after prosecutors charged its co-founder and tw...
Nvidia pulls off a landmark $20B Groq deal that could reshape AI inference in 2026. This piece breaks down the tech, ...
OpenAI is shutting down its Sora video app after a brief six-month run, a move that could reshape consumer AI tools a...
Netflix announces a second price increase in two years, boosting monthly costs for ad-supported and standard/premium ...
In a choppy market shaped by inflation and global tensions, three stocks stand out for potential to beat market retur...